Saturn V Capital Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Saturn V Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $4.73 Million - $9.16 Million	-374,209 Reduced 33.28%	750,250 $17.7 Billion
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $687,894 - $1.12 Million	-63,342 Reduced 5.33%	1,124,459 $16.8 Billion
Q2 2023 Aug 14, 2023	SELL	$7.47 - $10.95 $3.3 Million - $4.84 Million	-441,663 Reduced 27.1%	1,187,801 $13 Billion
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $103,993 - $169,608	17,686 Added 1.1%	1,629,464 $14.2 Billion
Q4 2022 Feb 09, 2023	BUY	$3.22 - $6.27 $5.19 Million - $10.1 Million	1,611,778 New	1,611,778 $5.72 Billion

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Saturn V Capital Management LLC with notifications on news.